Amy Bunker

453 total citations
13 papers, 356 citations indexed

About

Amy Bunker is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Amy Bunker has authored 13 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Amy Bunker's work include Synthesis and Characterization of Heterocyclic Compounds (3 papers), Synthesis and biological activity (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Amy Bunker is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (3 papers), Synthesis and biological activity (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Amy Bunker collaborates with scholars based in United States. Amy Bunker's co-authors include P.A. Elkins, Cynthia V. Stauffacher, William Cramer, Jeremy J. Edmunds, Thomas J. Delia, Markus Baumann, Jie Jack Li, Richard D. Dyer, Annette M. Doherty and Patrick O’Brien and has published in prestigious journals such as Journal of Medicinal Chemistry, Structure and European Journal of Medicinal Chemistry.

In The Last Decade

Amy Bunker

13 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Bunker United States 10 193 123 64 61 48 13 356
Jeong Hyeok Yoon South Korea 10 240 1.2× 119 1.0× 58 0.9× 86 1.4× 11 0.2× 20 478
Amit Ketkar United States 17 432 2.2× 127 1.0× 77 1.2× 60 1.0× 41 0.9× 30 603
J.-P. Marquette France 9 358 1.9× 61 0.5× 39 0.6× 47 0.8× 25 0.5× 9 644
Peter J. Coles Canada 10 225 1.2× 123 1.0× 104 1.6× 138 2.3× 14 0.3× 11 356
Walter Davidson United States 11 273 1.4× 132 1.1× 34 0.5× 75 1.2× 39 0.8× 18 547
Sherida L. Johnson United States 9 256 1.3× 97 0.8× 43 0.7× 78 1.3× 107 2.2× 10 382
Ivo Frydrych Czechia 12 234 1.2× 102 0.8× 26 0.4× 52 0.9× 21 0.4× 33 386
David G. Osterman United States 13 510 2.6× 61 0.5× 20 0.3× 48 0.8× 48 1.0× 16 672
J. L. Chambers United States 6 337 1.7× 33 0.3× 44 0.7× 54 0.9× 29 0.6× 7 470
Margaret F. Weidner United States 9 434 2.2× 113 0.9× 24 0.4× 157 2.6× 46 1.0× 9 605

Countries citing papers authored by Amy Bunker

Since Specialization
Citations

This map shows the geographic impact of Amy Bunker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Bunker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Bunker more than expected).

Fields of papers citing papers by Amy Bunker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Bunker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Bunker. The network helps show where Amy Bunker may publish in the future.

Co-authorship network of co-authors of Amy Bunker

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Bunker. A scholar is included among the top collaborators of Amy Bunker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Bunker. Amy Bunker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Li, Jie Jack, Adam R. Johnson, Amy Bunker, et al.. (2008). Quinazolinones and Pyrido[3,4- d ]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis. Journal of Medicinal Chemistry. 51(4). 835–841. 74 indexed citations
2.
Belema, Makonen, Amy Bunker, Van N. Nguyen, et al.. (2007). Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4284–4289. 26 indexed citations
3.
Springer, Dane M., Amy Bunker, Margaret E. Sorenson, et al.. (2006). Cyclopentanone ring-cleaved pleuromutilin derivatives. European Journal of Medicinal Chemistry. 42(1). 109–113. 14 indexed citations
4.
Dudley, Danette A., Amy Bunker, Liguo Chi, et al.. (2000). Rational Design, Synthesis, and Biological Activity of Benzoxazinones as Novel Factor Xa Inhibitors. Journal of Medicinal Chemistry. 43(22). 4063–4070. 37 indexed citations
5.
Edmunds, Jeremy J., et al.. (1998). Endothelin receptor antagonists: synthesis and structure–activity relationships of substituted benzothiazine-1,1-dioxides. Bioorganic & Medicinal Chemistry. 6(9). 1447–1456. 12 indexed citations
6.
Elkins, P.A., Amy Bunker, William Cramer, & Cynthia V. Stauffacher. (1997). A mechanism for toxin insertion into membranes is suggested by the crystal structure of the channel-forming domain of colicin E1. Structure. 5(3). 443–458. 117 indexed citations
7.
Bunker, Amy, et al.. (1996). 1-benzyl-3-thioaryl-2-carboxyindoles as potent non-peptide endothelin antagonists. Bioorganic & Medicinal Chemistry Letters. 6(12). 1367–1370. 9 indexed citations
8.
Bunker, Amy, et al.. (1996). 1,3-diaryl-2-carboxyindoles as potent non-peptide endothelin antagonists. Bioorganic & Medicinal Chemistry Letters. 6(9). 1061–1066. 18 indexed citations
9.
Edmunds, Jeremy J., S. KLUTCHKO, James M. Hamby, et al.. (1996). ChemInform Abstract: Derivatives of 5‐((1‐(4′‐Carboxybenzyl)imidazolyl)methylidene) hydantoins as Orally Active Angiotensin II Receptor Antagonists.. ChemInform. 27(3). 1 indexed citations
10.
Edmunds, Jeremy J., S. KLUTCHKO, James M. Hamby, et al.. (1995). Derivatives of 5-[[1-4(4-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 38(19). 3759–3771. 20 indexed citations
11.
Delia, Thomas J., Markus Baumann, & Amy Bunker. (1993). Fused Pyrimidines. Part 5. Pyrimido[4,5-d]pyrimidine Analogues of Folic Acid. Heterocycles. 35(2). 1397–1397. 22 indexed citations
12.
13.
Delia, Thomas J., Marc Baumann, & Amy Bunker. (1993). ChemInform Abstract: Fused Pyrimidines. Part 5. Pyrimido(4,5‐d)pyrimidine Analogues of Folic Acid.. ChemInform. 24(52). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeong Hyeok Yoon Breakdown of academic impact, for papers by Amit Ketkar Breakdown of academic impact, for papers by J.-P. Marquette Breakdown of academic impact, for papers by Peter J. Coles Breakdown of academic impact, for papers by Walter Davidson Breakdown of academic impact, for papers by Sherida L. Johnson Breakdown of academic impact, for papers by Ivo Frydrych Breakdown of academic impact, for papers by David G. Osterman Breakdown of academic impact, for papers by J. L. Chambers Breakdown of academic impact, for papers by Margaret F. Weidner
Rankless by CCL
2026